SE9200541D0 - New usee of omega-3-fatty acids - Google Patents
New usee of omega-3-fatty acidsInfo
- Publication number
- SE9200541D0 SE9200541D0 SE9200541A SE9200541A SE9200541D0 SE 9200541 D0 SE9200541 D0 SE 9200541D0 SE 9200541 A SE9200541 A SE 9200541A SE 9200541 A SE9200541 A SE 9200541A SE 9200541 D0 SE9200541 D0 SE 9200541D0
- Authority
- SE
- Sweden
- Prior art keywords
- omega
- pct
- preparations
- fatty acids
- dic
- Prior art date
Links
- 229940012843 omega-3 fatty acid Drugs 0.000 title abstract 4
- 235000020660 omega-3 fatty acid Nutrition 0.000 title abstract 4
- 239000006014 omega-3 oil Substances 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 abstract 4
- 208000009190 disseminated intravascular coagulation Diseases 0.000 abstract 2
- 239000000443 aerosol Substances 0.000 abstract 1
- 230000004872 arterial blood pressure Effects 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 210000001147 pulmonary artery Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 235000013311 vegetables Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Priority Applications (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9200541A SE9200541D0 (sv) | 1992-02-24 | 1992-02-24 | New usee of omega-3-fatty acids |
| DK93905710T DK0627918T3 (da) | 1992-02-24 | 1993-02-23 | Ny anvendelse af omega-3-fedtsyrer |
| JP51475493A JP3559280B2 (ja) | 1992-02-24 | 1993-02-23 | オメガ−３−脂肪酸の用法 |
| CA002117535A CA2117535A1 (en) | 1992-02-24 | 1993-02-23 | New use of omega-3-fatty acids |
| EP93905710A EP0627918B1 (en) | 1992-02-24 | 1993-02-23 | New use of omega-3-fatty acids |
| ES93905710T ES2162620T3 (es) | 1992-02-24 | 1993-02-23 | Nuevo uso de los acidos grasos omega 3. |
| US08/290,905 US5747533A (en) | 1992-02-24 | 1993-02-23 | Use of ω-3-fatty acids |
| SG1996001422A SG46238A1 (en) | 1992-02-24 | 1993-02-23 | New use of omega-3-fatty acids |
| PCT/SE1993/000146 WO1993016691A1 (en) | 1992-02-24 | 1993-02-23 | New use of omega-3-fatty acids |
| AU36529/93A AU671438B2 (en) | 1992-02-24 | 1993-02-23 | New use of omega-3-fatty acids |
| DE69331051T DE69331051T2 (de) | 1992-02-24 | 1993-02-23 | Neue verwendung von omega-3-fettsäuren |
| AT93905710T ATE207744T1 (de) | 1992-02-24 | 1993-02-23 | Neue verwendung von omega-3-fettsäuren |
| NO943102A NO309704B1 (no) | 1992-02-24 | 1994-08-23 | Anvendelse av <omega>-3-fettsyrer for fremstilling av et medisinsk preparat for behandling eller for forhindring av utvikling av disseminert, intravaskulær koagulasjon (DIC) |
| US08/483,977 US5731346A (en) | 1992-02-24 | 1995-06-07 | Use of omega-3-fatty acids |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9200541A SE9200541D0 (sv) | 1992-02-24 | 1992-02-24 | New usee of omega-3-fatty acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9200541D0 true SE9200541D0 (sv) | 1992-02-24 |
Family
ID=20385410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9200541A SE9200541D0 (sv) | 1992-02-24 | 1992-02-24 | New usee of omega-3-fatty acids |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US5747533A (sv) |
| EP (1) | EP0627918B1 (sv) |
| JP (1) | JP3559280B2 (sv) |
| AT (1) | ATE207744T1 (sv) |
| AU (1) | AU671438B2 (sv) |
| CA (1) | CA2117535A1 (sv) |
| DE (1) | DE69331051T2 (sv) |
| DK (1) | DK0627918T3 (sv) |
| ES (1) | ES2162620T3 (sv) |
| NO (1) | NO309704B1 (sv) |
| SE (1) | SE9200541D0 (sv) |
| SG (1) | SG46238A1 (sv) |
| WO (1) | WO1993016691A1 (sv) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0987176A (ja) * | 1995-09-26 | 1997-03-31 | Shiseido Co Ltd | 糸球体腎炎抑制剤 |
| WO1998057628A1 (fr) * | 1997-06-16 | 1998-12-23 | Nippon Suisan Kaisha, Ltd. | Composition capable de supprimer le facteur de risque pendant l'exercice |
| BR9917806B1 (pt) * | 1998-01-21 | 2013-06-18 | composiÇço de feromona para tratamento de estresse ou ansiedade em mamÍferos, e soluÇço. | |
| US6054481A (en) * | 1998-01-21 | 2000-04-25 | Fideline | Pig appeasing pheromones for enhancing weight gain in a mammal |
| US6077867A (en) * | 1998-01-21 | 2000-06-20 | Fideline | Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| JP2003514855A (ja) * | 1999-10-13 | 2003-04-22 | チャコン，マルコ，エー． | カロリー制限の効果を模倣した治療的介入 |
| FR2804023B1 (fr) * | 2000-01-26 | 2002-09-20 | Johnson & Johnson Consumer Fr | Complement nutritionnel a base d'huile de pepins de cassis |
| US6864242B2 (en) * | 2001-03-05 | 2005-03-08 | Stephen P. Ernest | Enteral formulation |
| US8729124B2 (en) * | 2002-03-05 | 2014-05-20 | Pronova Biopharma Norge As | Use of EPA and DHA in secondary prevention |
| US7323206B1 (en) | 2003-03-04 | 2008-01-29 | B. Braun Medical Inc. | Reagents and methods for all-in-one total parenteral nutrition for neonates and infants |
| US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| WO2006036967A1 (en) | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Solubilizing a drug for use in a coating |
| US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
| US8795703B2 (en) | 2004-09-28 | 2014-08-05 | Atrium Medical Corporation | Stand-alone film and methods for making the same |
| US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| US20060135610A1 (en) * | 2004-12-22 | 2006-06-22 | Bortz Jonathan D | Cardiovascular compositions |
| BRPI0611710A2 (pt) * | 2005-06-24 | 2011-12-20 | Drugrecure Aps | administração às vias aéreas de inibidor do passo de fator tissular, em condições inflamatórias que afetam o trato respiratório |
| US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
| US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
| JP2009525992A (ja) * | 2006-02-10 | 2009-07-16 | スポーツコム デンマーク アプス | コーティングを施した錠剤、その製造方法、及び関連する使用 |
| US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
| EP2083875B1 (en) | 2006-11-06 | 2013-03-27 | Atrium Medical Corporation | Coated surgical mesh |
| US20080207756A1 (en) * | 2007-02-27 | 2008-08-28 | Atrium Medical Corporation | Bio-absorbable oil suspension |
| US20090011012A1 (en) * | 2007-07-06 | 2009-01-08 | Baum Seth J | Fatty acid compositions and methods of use |
| EP2214481B1 (en) | 2007-10-15 | 2019-05-01 | United Animal Health, Inc. | Method for increasing performance of offspring |
| CA2704371A1 (en) * | 2007-11-01 | 2009-05-07 | Wake Forest University School Of Medicine | Compositions and methods for prevention and treatment of mammalian diseases |
| US8343753B2 (en) * | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
| US20100323028A1 (en) * | 2007-11-30 | 2010-12-23 | Jbs United, Inc. | Method and composition for treating pulmonary hemorrhage |
| US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
| US20110045050A1 (en) * | 2009-08-24 | 2011-02-24 | Atrium Medical Corporation | Nanoemulsion formulations for direct delivery |
| US20110206741A1 (en) * | 2010-02-18 | 2011-08-25 | Martek Biosciences Corporation | DHA Triglyceride Emulsions |
| WO2011103512A1 (en) * | 2010-02-18 | 2011-08-25 | Martek Biosciences Corporation | Dha free fatty acid emulsions |
| EP2593141B1 (en) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
| US20210176999A1 (en) | 2011-04-17 | 2021-06-17 | Omega Foods, LLC | Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids |
| US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
| US9216199B2 (en) | 2013-12-05 | 2015-12-22 | Buriva, LLC | Nutritional supplement containing phospholipid-DHA derived from eggs |
| US9549937B2 (en) | 2013-12-05 | 2017-01-24 | Burvia, LLC. | Composition containing phospholipid-DHA and folate |
| US9233114B2 (en) | 2013-12-05 | 2016-01-12 | Buriva, LLC | Dietary supplement containing phospholipid-DHA derived from eggs |
| US9610302B2 (en) | 2013-12-05 | 2017-04-04 | Buriva, LLC. | Composition containing phospholipid-DHA and B vitamins |
| US10183044B2 (en) | 2015-05-15 | 2019-01-22 | P Tech, Llc | Systems and methods for thrombosis prevention |
| US9655847B1 (en) * | 2016-07-18 | 2017-05-23 | National Guard Health Affairs | Therapeutic liposome and method of treating a subject having cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4752618A (en) * | 1984-07-12 | 1988-06-21 | New England Deaconess Hospital | Method of minimizing efects of infection through diet |
| US4678808A (en) * | 1985-10-15 | 1987-07-07 | Baxter Travenol Laboratories, Inc. | Rapid acting intravenous emulsions of omega-3 fatty acid esters |
| ATE88631T1 (de) * | 1986-09-17 | 1993-05-15 | Clintec Nutrition Co | Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen. |
| DE3719097C1 (de) * | 1987-06-06 | 1988-06-09 | Fratzer Uwe | Arzneimittel,enthaltend Eicosapentaensaeure und Docosahexaensaeure als ungesaettigte Fettsaeuren sowie Vitamin E |
| GB8729751D0 (en) * | 1987-12-21 | 1988-02-03 | Norsk Hydro As | Feed additive & feed containing such additive |
| GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
| US5223285A (en) * | 1992-03-31 | 1993-06-29 | Abbott Laboratories | Nutritional product for pulmonary patients |
-
1992
- 1992-02-24 SE SE9200541A patent/SE9200541D0/sv unknown
-
1993
- 1993-02-23 WO PCT/SE1993/000146 patent/WO1993016691A1/en not_active Ceased
- 1993-02-23 ES ES93905710T patent/ES2162620T3/es not_active Expired - Lifetime
- 1993-02-23 AT AT93905710T patent/ATE207744T1/de active
- 1993-02-23 JP JP51475493A patent/JP3559280B2/ja not_active Expired - Lifetime
- 1993-02-23 CA CA002117535A patent/CA2117535A1/en not_active Abandoned
- 1993-02-23 DK DK93905710T patent/DK0627918T3/da active
- 1993-02-23 AU AU36529/93A patent/AU671438B2/en not_active Ceased
- 1993-02-23 US US08/290,905 patent/US5747533A/en not_active Expired - Lifetime
- 1993-02-23 DE DE69331051T patent/DE69331051T2/de not_active Expired - Lifetime
- 1993-02-23 EP EP93905710A patent/EP0627918B1/en not_active Expired - Lifetime
- 1993-02-23 SG SG1996001422A patent/SG46238A1/en unknown
-
1994
- 1994-08-23 NO NO943102A patent/NO309704B1/no not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/483,977 patent/US5731346A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0627918B1 (en) | 2001-10-31 |
| AU3652993A (en) | 1993-09-13 |
| US5747533A (en) | 1998-05-05 |
| CA2117535A1 (en) | 1993-09-02 |
| NO943102D0 (no) | 1994-08-23 |
| AU671438B2 (en) | 1996-08-29 |
| US5731346A (en) | 1998-03-24 |
| SG46238A1 (en) | 1998-02-20 |
| JPH07507766A (ja) | 1995-08-31 |
| DE69331051D1 (de) | 2001-12-06 |
| WO1993016691A1 (en) | 1993-09-02 |
| ATE207744T1 (de) | 2001-11-15 |
| DK0627918T3 (da) | 2002-01-14 |
| EP0627918A1 (en) | 1994-12-14 |
| JP3559280B2 (ja) | 2004-08-25 |
| ES2162620T3 (es) | 2002-01-01 |
| DE69331051T2 (de) | 2002-06-13 |
| NO309704B1 (no) | 2001-03-19 |
| NO943102L (no) | 1994-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9200541D0 (sv) | New usee of omega-3-fatty acids | |
| Evans | Alcoholic cardiomyopathy | |
| Stephen et al. | Scurvy identified in the emergency department: a case report | |
| La Brooy et al. | Controlled trial of cimetidine in upper gastrointestinal haemorrhage. | |
| Master et al. | Factors in the onset of coronary occlusion and coronary insufficiency: effort, occupation, trauma, and emotion | |
| DE59407237D1 (de) | Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems | |
| ZA200202990B (en) | Water and oil containing emulsion. | |
| DOMSCHKE et al. | Gastroduodenal damage due to drugs, alcohol and smoking | |
| ATE218350T1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
| Kim et al. | Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat. | |
| Brown et al. | Dietary protein intake and the glomerular adaptations to partial nephrectomy in dogs | |
| KR910000158A (ko) | 의약용 화합물 및 그것의 사용방법 | |
| Roba et al. | Antiplatelet and antithrombogenic effects of suloctidil | |
| HUP9801593A2 (hu) | Benazeprilt vagy benazeprilátot és valzartánt tartalmazó kombinált gyógyszerkészítmények és azok alkalmazása | |
| BR9708388A (pt) | Solução aquosa de hemoglobina polimerizada piridoxilada e processo de sua preparação. | |
| FR2773712B1 (fr) | Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a | |
| DE69329687D1 (de) | Verwendung von aspirin zur herstellung eines arzneimittels zur verbesserung fer blutperfusion des uterus | |
| DE3584131D1 (de) | Methode zur behandlung der antidiurese. | |
| DE58906606D1 (de) | Optisch aktive Rhodiumkomplexe von 3,4-Bis(diarylphosphino)-pyrrolidinen und ihre Verwendung zur Herstellung von Phosphinothricin durch asymmetrische Hydrierung. | |
| FR2603587A1 (fr) | Derives de la 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonine (ou -1,4-benzoxazonine), procede pour leur preparation, medicaments les contenant et composes intermediaires | |
| KR880010762A (ko) | 소화성궤양의 치료방법 및 치료용 합성물(Composition and Method for Treatment of peptic Ulcers) | |
| Lichtenstein et al. | Nonsteroidal Anti-inflammatory Drugs: Their Use in Dermatology. | |
| NO975155L (no) | Anvendelse av forskolin eller ekstakter inneholdende denne ved fremstilling av et medikament for behandling av alkoholavhengighet | |
| Al Aboud | Medical Eponyms linked to nails | |
| Unsworth | HTLV-III infection in spouses of haemophiliacs |